Floatz logo

Ganciclovir

HIV Infections

Small moleculePhase 4 / ApprovedDormant
BBB
76/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
73/ 100
Competitive Position
81/ 100

Competitive context

62 Active assets in the HIV Infections cohort.

Asset / SponsorPhaseRating
Raltegravir
Helsinki University Central Hospital
Phase 4A
ZIDOVUDINE
International Maternal Pediatric Adolescent AIDS Clinical Trials Group
Phase 4BBB
Efavirenz
The Cleveland Clinic
Phase 4BBB
Dolutegravir
Instituto Mexicano del Seguro Social
Phase 4BBB
Abacavir
Germans Trias i Pujol Hospital
Phase 4BBB

View all 50 →

Same molecule, other indications

Ganciclovir is also rated in:

cytomegalovirus retinitisDormant
A
Indicative ·
82 / 100
View asset →
cytomegalovirus infectionDormant
BB
Indicative ·
67 / 100
View asset →
lymphomaDormant
B
Indicative ·
61 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →